A Trial to Evaluate the Efficacy and Safety of YH12852 in Patients With Functional Dyspepsia
Status:
Suspended
Trial end date:
2020-01-01
Target enrollment:
Participant gender:
Summary
This is a multicenter, randomized, double-blind, placebo-controlled dose-finding phase 2
trial to evaluate the efficacy and safety of YH12852 in patients with functional dyspepsia.